(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s ...
As more Americans receive treatment for opioid-use disorder, that progress is increasingly showing up in the operating room, ...
Ohio Gov. Mike DeWine recently banned the sale and use of nine synthetic opioids, compounds called nitazenes that are stronger than fentanyl, in the state. Theses man-made opioids were never approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback